TheraRadar
← Back
Data updated: Mar 29, 2026

APPCO

GastroenterologyCardiovascular
Generics

APPCO is a generic drug manufacturer focused on Gastroenterology, Cardiovascular.

2007
Since
19
Drugs
-
Trials
181
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

GLYCOPYRROLATE 2026-02-10
Labeling
GLYCOPYRROLATE 2026-02-06
Labeling
BUMETANIDE 2026-02-05
PRUCALOPRIDE SUCCINATE 2026-02-05
PRUCALOPRIDE SUCCINATE 2026-01-29
Labeling
SERTRALINE HYDROCHLORIDE 2026-01-29
SERTRALINE HYDROCHLORIDE 2026-01-28
TRANEXAMIC ACID 2026-01-26
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Gastroenterology 67%
2 drugs
Cardiovascular 33%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

BAUSCH specialty
Cardiovascular, Gastroenterology
APOTHECON specialty
Cardiovascular, Gastroenterology
VALIDUS PHARMS specialty
Cardiovascular, Gastroenterology
WAYLIS THERAP big-pharma
Cardiovascular, Gastroenterology
WARNER CHILCOTT LLC specialty
Cardiovascular, Gastroenterology